Biocytogen Launches AI-Powered RenSuper Platform to Accelerate Therapeutic Antibody Discovery
Biocytogen unveils RenSuper, a next-generation AI-driven antibody discovery and automation platform designed to streamline therapeutic biologics development and accelerate the delivery of innovative medicines worldwide.
Biocytogen | 28/05/2026 | By News Bureau | 117
GVSAP Join Hands with Biocytogen to Accelerate Biopharmaceutical Innovation
GV Safety Assessment Platform (GVSAP) has forged a groundbreaking partnership with Biocytogen, a leader in industry-leading technologies that propel drug discovery.
Biocytogen | 20/05/2024 | By Aishwarya | 471
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy